Xiao Yan

429 total citations
22 papers, 315 citations indexed

About

Xiao Yan is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Xiao Yan has authored 22 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Hematology. Recurrent topics in Xiao Yan's work include Hematopoietic Stem Cell Transplantation (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Phytochemicals and Antioxidant Activities (2 papers). Xiao Yan is often cited by papers focused on Hematopoietic Stem Cell Transplantation (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Phytochemicals and Antioxidant Activities (2 papers). Xiao Yan collaborates with scholars based in China and United States. Xiao Yan's co-authors include Heather A. Himburg, John P. Chute, Wenhua Ling, Dongliang Wang, Tangbin Zou, Yan Yang, Mamle Quarmyne, Phuong L. Doan, Nelson J. Chao and Joshua Sasine and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Blood.

In The Last Decade

Xiao Yan

19 papers receiving 315 citations

Peers

Xiao Yan
Comparison fields: 5 of 77
  • Molecular Biology 146
  • Hematology 85
  • Oncology 64
  • Immunology 62
  • Genetics 36
Replace Zakar Mnjoyan with:
Zakar Mnjoyan United States
Xinan Wang China
Jérôme Bourgeais France
David O. Osei-Hwedieh United States
Jayna J. Mistry United Kingdom
Domenico Mastrangelo Italy
John H. Baird United States
Stephan Meinke Sweden
Zakar Mnjoyan United States View profile →
Citations per field, relative to Xiao Yan
Xiao Yan · 1×
Citations per year, relative to Xiao Yan
Xiao Yan · 1×

Countries citing papers authored by Xiao Yan

Since Specialization
Citations

This map shows the geographic impact of Xiao Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao Yan more than expected).

Fields of papers citing papers by Xiao Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao Yan. The network helps show where Xiao Yan may publish in the future.

Co-authorship network of co-authors of Xiao Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao Yan. A scholar is included among the top collaborators of Xiao Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao Yan. Xiao Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 0
3 12
4 5
5 4
6 1
7 7
8 21
9 0
10 10
11 6
12 50
13 63
14 26
15 39
16 2
17 62
18 1
19
[Main factors affecting the effect of photodynamic therapy against human esophageal cancer cells in vitro].
1
20 1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026